Program:
* New Developments in Human Hematopoietic Stem Cell Technologies.
* Gene Therapy Approaches Reducing Graft Versus Host Disease.
* In Vivo Production Gene Therapy for Chronic Granulomatous Disease: Ex Vivo Transduction
* Automated Closed System Hematopoietic Cell Expansion.
Registration :
Deadline for Abstracts: May 23-, 1999
Email for Requests and Registration: inq@ibcusa.com